Equity Details
Price & Market Data
Price: $2.12
Daily Change: $0.00 / 0.00%
Daily Range: $0 - $0
Market Cap: $790,676,160
Daily Volume: 0
Performance Metrics
1 Week: -6.84%
1 Month: -3.45%
3 Months: -6.84%
6 Months: -20.15%
1 Year: 40.66%
YTD: -11.50%
About Clarity Pharmaceuticals Ltd (CLRPF)
Stay ahead with market insights for Clarity Pharmaceuticals Ltd (CLRPF). The stock is currently at 2.12, having moved by $0.00 / 0.00% today. Its impressive market capitalization is 790,676,160. Find out how it has performed year-to-date and over 1, 3, 6, and 12 months.
Details
Clarity Pharmaceuticals Ltd, a clinical stage radiopharmaceutical company, engages in research and development of radiopharmaceuticals products for oncology in Australia and the United States. The company's lead product is SAR-bisPSMA, a theranostic radiopharmaceutical for the treatment of Prostate Specific Membrane Antigen (PSMA) cancer. It also develops SAR-Bombesin, a pan cancer theranostic radiopharmaceutical to treat prostate, breast, ovarian, urinary, small cell lung cancer, as well as glioblastoma and gastrointestinal stromal tumours; and SARTATE, a theranostic radiopharmaceutical for the treatment of somatostatin receptor 2 (SSTR2) cancer. The company was incorporated in 2010 and is based in Sydney, Australia.